In this Issue
Upcoming Trial Readouts to Watch
Lykos Prioritises Preparing for Resubmission Over Formal Dispute
Bogenschutz Scores $3.8m NIAAA Grant for Psilocybin in Alcohol Use Disorder Study
FDA Issues Decentralised Clinical Trials Guidance
New Mental Health Parity Regs Come Into Force in January 2025
More Headlines from Cybin, Bright Minds Biosciences, Richard Branson, Psychedelic Industry UK, Incannex, Big Health, Lophora, and others.
***
Upcoming Trial Readouts to Watch
Sign-in or join Pα+ to continue reading this Issue of the Psychedelic Bulletin…
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture.
Subscribe AnnuallySubscribe Monthly
Already a member? Log In
✓ Regular Bulletins covering key topics and trends in the psychedelics space✓ Regular articles and deep dives across psychedelic research, policy and business✓ Interviews with insiders✓ Monthly interactive database and commentary on psychedelic patents✓ Quick-take analysis of major developments✓ A Library of primers and explainers✓ Access to our full back catalogue
Learn more about Pα+
